ITCH - itchy E3 ubiquitin protein ligase Gene
Species: Sus scrofa
Gene Type: ncRNA
Gene ID: 102165807
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(10)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-B0548A | Hydroxyzine dihydrochloride | Antagonist | 99.59% | Unkown |
| HY-B0548 | Hydroxyzine | Antagonist | 99.72% | Unkown |
| HY-B1183 | Hydrocortisone acetate | Agonist | 99.07% | Yes |
| HY-A0075 | Decloxizine dihydrochloride | Antagonist | 99.69% | Unkown |
| HY-B1173 | (+)-Camphor | Inhibitor | 98.94% | Unkown |
| HY-106566 | Alclometasone dipropionate | ≥96.0% | Unkown | |
| HY-17582 | Decloxizine | Antagonist | 99.80% | Unkown |
| HY-P3445 | Anrikefon | Agonist | / | Unkown |
| HY-17582R | Decloxizine (Standard) | Antagonist | / | Unkown |
| HY-A0075R | Decloxizine dihydrochloride (Standard) | Antagonist | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P99025 | Lebrikizumab | Inhibitor | 99.90% | Unkown |
| HY-P99162 | Nemolizumab | Inhibitor | 99.70% | Unkown |
Clinical Phase
Bioactive Molecules
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-14939 | Vapitadine | 99.77% | Phase 2 |
Pre-clinical Phase
Bioactive Molecules
(35)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-129047 | Trypsin | Activator | 91.00% | Unkown |
| HY-129047A | Trypsin (MS grade) | Activator | 95.00% | Unkown |
| HY-118069 | (R)-ZINC-3573 | Agonist | 99.83% | Unkown |
| HY-148949 | Kallikrein 5-IN-2 | 99.46% | Unkown | |
| HY-103368 | Eact | Activator | 98.86% | Unkown |
| HY-165559 | Trpvicin | Inhibitor | 99.4% | Unkown |
| HY-148244 | MS47134 | 99.69% | Unkown | |
| HY-147051 | Nelremagpran | 99.94% | Unkown | |
| HY-103320A | Calhex 231 hydrochloride | Inhibitor | 99.81% | Unkown |
| HY-145997 | MRGPRX4 modulator-1 | 98.96% | Unkown | |
| HY-B1144A | Chlormidazole hydrochloride | Inhibitor | 99.45% | Unkown |
| HY-143481 | Nav1.8-IN-2 | Inhibitor | 99.83% | Unkown |
| HY-103320B | (1R,2R)-Calhex 231 hydrochloride | Control | 98.45% | Unkown |
| HY-171366 | lirucitinib | Inhibitor | 98.72% | Unkown |
| HY-108425B | (Rac)-AMG8379 | Antagonist | 99.25% | Unkown |
| HY-145153 | S-777469 | Agonist | 98.19% | Unkown |
| HY-163840 | GFRα2/3-IN-1 | Inhibitor | / | Unkown |
| HY-153275A | KM-001-E2 | 99.08% | Unkown | |
| HY-108425 | AMG8379 | Antagonist | / | Unkown |
| HY-103320 | Calhex 231 | Antagonist | / | Unkown |
| HY-108425A | AMG8380 | Inhibitor | / | Unkown |
| HY-124356 | Alcaftadine carboxylic acid | / | Unkown | |
| HY-124356AS | Alcaftadine carboxylic acid-d3 sodium | / | Unkown | |
| HY-135495 | AM-0466 | Inhibitor | / | Unkown |
| HY-157496 | EP3 antagonist 7 | Antagonist | / | Unkown |
| HY-175672 | MRGPRX4 modulator-3 | Modulator | / | Unkown |
| HY-182517 | AG1529 | Antagonist | / | Unkown |
| HY-182710 | DA-0218 | Inhibitor | / | Unkown |
| HY-P5357 | SFNGGP-NH2 | / | Unkown | |
| HY-RS06943 | ITCH Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W665882 | Norketotifen | Inhibitor | / | Unkown |
| HY-167645 | Pramocaine | / | Unkown | |
| HY-N12040 | γ-Isofagarine | / | Unkown | |
| HY-RS17888 | Itch Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS24357 | Itch Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Homo sapiens | ITCH | NCBI | NCBI:83737 |
| Mus musculus | ITCH | NCBI | NCBI:16396 |